Provident Financial Services, Inc. (PFS) Market Cap & Valuation Ratios
Provident Financial Services, Inc. (PFS) has a market cap of $3.0B, a trailing P/E of 9.7 and a price-to-sales ratio of 3.3, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PFSProvident Financial Services, Inc.Follow PFS — free
—
Price chart with a free account
- Market cap
- 3.0B
- P/E TTM
- 9.7
- Dividend yield
- 4.1%
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Peers
banks - regional · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | P/B | ROE | Div. yield | Rev. growth |
|---|---|---|---|---|---|---|
| PFS | 3.0 | 9.7 | 1.04 | 11% | 4.1% | +8% |
| PRK | 3.3 | 16.4 | 1.91 | 11% | 3.1% | +15% |
| CBU | 3.3 | 14.5 | 1.58 | 12% | 3.0% | +10% |
| SBCF | 3.2 | 21.7 | 1.19 | 6% | 2.2% | +32% |
| BKU | 3.1 | 11.9 | 1.03 | 9% | 2.9% | +7% |
| FHB | 3.1 | 11.0 | 1.09 | 10% | 4.1% | +9% |
| BANC | 3.0 | — | 0.89 | -0.7% | 2.5% | -13% |
| CLBK | 2.9 | — | 2.44 | — | — | — |
| CUBI | 2.9 | 10.3 | 1.29 | 14% | — | +35% |
| BOH | 2.8 | 13.2 | 1.49 | 13% | 4.0% | +14% |
| NBTB | 2.7 | 12.9 | 1.41 | 11% | 2.8% | +19% |
| Median of these 10 | 13.0 | 1.35 | 11% | 3.0% | +14% |
P/E 9.7 vs. a peer median of 13.0; P/B 1.04 vs. 1.35. PFS's own P/E sits at the 34th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesBANC and CLBK have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Provident Financial Services, Inc. — questions
- What is Provident Financial Services, Inc.'s market cap?
- $3.0B.
- What is Provident Financial Services, Inc.'s P/E ratio?
- 9.7 on trailing twelve-month earnings to 2026-06-30.
- What is Provident Financial Services, Inc.'s price-to-sales ratio?
- 3.3.
Every figure on this page comes from Provident Financial Services, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.